Electra Therapeutics, Inc. (ETRA)
NASDAQ: ETRA · Real-Time Price · USD
8.37
-0.34 (-3.90%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Electra Therapeutics Market Cap
Electra Therapeutics has a market cap or net worth of $525.36 million as of October 26, 2026. It is the 14,129th most valuable company in the world and the 2,695th biggest in the United States.
Market Cap
525.36M
Enterprise Value
429.62M
1-Year Change
n/a
Global Rank
Country Rank
#2,695 United States
Category
ChartMarket Cap Chart
Since the IPO on September 18, 2026, Electra Therapeutics's market cap has decreased from $916.50M to $525.36M, a decrease of -42.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 525.36M | -3.90% |
| Oct 23, 2026 | 546.70M | -5.84% |
| Oct 22, 2026 | 580.59M | 2.21% |
| Oct 21, 2026 | 568.04M | 2.72% |
| Oct 20, 2026 | 552.98M | 2.32% |
| Oct 19, 2026 | 540.42M | -1.60% |
| Oct 16, 2026 | 549.21M | - |
| Oct 15, 2026 | 549.21M | -2.13% |
| Oct 14, 2026 | 561.14M | 3.83% |
| Oct 13, 2026 | 540.42M | -7.62% |
| Oct 12, 2026 | 584.99M | 3.10% |
| Oct 9, 2026 | 567.41M | -1.09% |
| Oct 8, 2026 | 573.69M | -0.22% |
| Oct 7, 2026 | 574.95M | -6.72% |
| Oct 6, 2026 | 616.37M | 0.82% |
| Oct 5, 2026 | 611.35M | -6.08% |
| Oct 2, 2026 | 650.89M | -2.90% |
| Oct 1, 2026 | 670.35M | -5.07% |
| Sep 30, 2026 | 706.13M | -0.88% |
| Sep 29, 2026 | 712.40M | 0.27% |
| Sep 28, 2026 | 710.52M | -1.99% |
| Sep 25, 2026 | 724.96M | -2.28% |
| Sep 24, 2026 | 741.91M | -6.71% |
| Sep 23, 2026 | 795.26M | -6.98% |
| Sep 22, 2026 | 854.89M | -2.16% |
| Sep 21, 2026 | 873.72M | -4.67% |
| Sep 18, 2026 | 916.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 585.28M |
| Zevra Therapeutics | 582.55M |
| MiMedx Group | 569.92M |
| DBV Technologies | 569.30M |
| Puma Biotechnology | 568.85M |
| Olema Pharmaceuticals | 560.86M |
| Aclaris Therapeutics | 552.00M |
| Shattuck Labs | 550.99M |